ImaBiotech hires Mathieu Gaudin as the Laboratory Manager of the EU facility
ImaBiotech SAS is pleased to announce the hiring of Mathieu Gaudin as the Laboratory Manager of the EU facility. Dr. Mathieu Gaudin has been trained as a Chemist since his Chemical Engineering degree. During his Ph.D. at Paris Descartes University (France), he developed untargeted and semi-targeted mass spectrometry-based approaches for lipidomic characterization of brain tissue samples by liquid chromatography mass spectrometry to better understand the physiopathology of Alzheimer’s disease.
As a Research Associate at the Faculty of Medicine of Imperial College London, he continued to develop lipidomic approaches using UPLC-MS/MS to quantify low abundant oxylipins involved in inflammatory processes. He also contributed to the development of plasma sample preparation procedure for lipid profiling for the NIHR-MRC Phenone Centre.
He then moved back to France to join the Center of Excellence in Pharmacokinetics at Servier Laboratories in Orléans where he contributed to the drug distribution strategy and managed the Mass Spectrometry Imaging facility for four years to support drug discovery and development programs. He was also study responsible in pharmacokinetics and metabolism and involved in the corporate program stimulating participative innovation.
As a Laboratory Manager, he will be responsible for ImaBiotech EU service activities. Being in charge of the project coordination and the development of new analytical chemistry tools he will bring to Imabiotech its DMPK expertise and its understanding of pharmaceutical stakes.
He is also a board member of the French Society for Mass Spectrometry.
« His great career path and professional experience will help ImaBiotech’s expansion » says Jonathan Stauber, ImaBiotech’s founder.